US-based Veradigm Inc., has invested in Holmusk, a global behavioral health real-world evidence and data analytics company, headquartered in Singapore. Holmusk plans to leverage the investment to continue the rapid expansion of its flagship offering, the NeuroBlu Database – a leading source of real-world clinical data for the behavioral health industry. Holmusk is on a mission to harness real-world data to transform both research and care for behavioral health. Combining the leading behavioral health database with AI-powered analytics and digital solutions designed to address the most pressing challenges in behavioral health
Veradigm and Holmusk intend to enter into a data partnership to bring cohorts of behavioral health and related de-identified patient data from Veradigm to the NeuroBlu Database, significantly adding to Holmusk’s real-world clinical data asset. According to Holmusk, the investment will enable it to continue its work in curating and enhancing data as it plans to build the world’s largest platform for behavioral health data.